個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Molecular Insight Pharmaceuticals, Inc.
內容大綱
Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to raise $7 million in Series B financing. Should it continue its current strategy or change its approach? Includes color exhibits.